Teva files challenge to Boehringer inhaler capsule patent
Healthcare
2018-12-20 3:12 pm
Generic drug giant Teva has filed a lawsuit seeking to have German pharmaceutical company Boehringer’s patent for an inhalation capsule, which is used to deliver the active drug in its blockbuster Spiriva asthma inhaler, declared invalid.
For information on rights and reprints, contact subscriptions@lawyerly.com.au